Journey Medical Corp
DERMAs of the close on Sep 25, 2026
Price
$6.14
Market cap
—
No recent share count on file
P/E (diluted TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
EPS (TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Journey Medical Corp Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 6 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 29, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| AMERICAN FINANCIAL GROUP INC | 2026-03-31 | 180,000 | Not shown | SEC filing |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2026-03-31 | 11,215 | Not shown | SEC filing |
| Ameritas Investment Partners, Inc. | 2026-03-31 | 1,239 | Not shown | SEC filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2026-03-31 | 463,202 | Not shown | SEC filing |
| Atria Investments, Inc | 2026-03-31 | 14,451 | Not shown | SEC filing |
| Russell Investments Group, Ltd. | 2026-03-31 | 1,301 | Not shown | SEC filing |
| CWM, LLC | 2026-03-31 | 55 | Not shown | SEC filing |
| UBS Group AG | 2026-03-31 | 390,138 | Not shown | SEC filing |
| Police & Firemen's Retirement System of New Jersey | 2026-03-31 | 4,002 | Not shown | SEC filing |
| Root Financial Partners, LLC | 2026-03-31 | 2 | Not shown | SEC filing |
| Summit Financial, LLC | 2026-03-31 | 379,807 | Not shown | SEC filing |
| Focus Partners Wealth | 2026-03-31 | 18,975 | Not shown | SEC filing |
| LAZARD ASSET MANAGEMENT LLC | 2026-03-31 | 44,898 | Not shown | SEC filing |
| BlackRock, Inc. | 2026-03-31 | 972,862 | Not shown | SEC filing |
| BARCLAYS PLC | 2026-03-31 | 4,622 | Not shown | SEC filing |
| Sterling Capital Management LLC | 2026-03-31 | 134 | Not shown | SEC filing |
| Bank of New York Mellon Corp | 2026-03-31 | 37,195 | Not shown | SEC filing |
| BOOTHBAY FUND MANAGEMENT, LLC | 2026-03-31 | 67,442 | Not shown | SEC filing |
| GOLDMAN SACHS GROUP INC | 2026-03-31 | 69,389 | Not shown | SEC filing |
| Gladstone Institutional Advisory LLC | 2026-03-31 | 26,571 | Not shown | SEC filing |
- Each value is checked against Journey Medical Corp's share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 20 rows: no share price from within three months of their report dates is on file, so they could not be checked.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- WASATCH ADVISORS LP: 1,316,275 shares reported 2025-12-31; 2,133,370 shares reported 2026-03-31.
- NEW YORK STATE COMMON RETIREMENT FUND: 5,500 shares reported 2025-12-31; 5,500 shares reported 2026-03-31.
- STATE OF WISCONSIN INVESTMENT BOARD: 45,795 shares reported 2025-12-31; 44,704 shares reported 2026-03-31.
- RHUMBLINE ADVISERS: 9,761 shares reported 2025-12-31; 10,927 shares reported 2026-03-31.
- GAMMA Investing LLC: 182 shares reported 2025-12-31; 101 shares reported 2026-03-31.
- STATE STREET CORP: 173,337 shares reported 2025-12-31; 237,288 shares reported 2026-03-31.
- DEUTSCHE BANK AG\: 11,560 shares reported 2025-12-31; 11,560 shares reported 2026-03-31.
- MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.: 6,672 shares reported 2025-12-31; 9,695 shares reported 2026-03-31.
- FMR LLC: 196 shares reported 2025-12-31; 2,194 shares reported 2026-03-31.
- Integrated Wealth Concepts LLC: 44,020 shares reported 2025-12-31; 40,369 shares reported 2026-03-31.
- J. Goldman & Co LP: 798,366 shares reported 2025-12-31; 500,188 shares reported 2026-03-31.
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC: 35,507 shares reported 2025-12-31; 45,331 shares reported 2026-03-31.
Showing the 12 most recent filer reports.
38 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Journey Medical Corp's recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-03-11 · Maraoui Claude: Larger than all 12 other insider sales of Common Stock, $0.0001 par value on file. SEC filing
- 2025-03-04 · Maraoui Claude: Larger than 11 of the 12 other insider sales of Common Stock, $0.0001 par value on file. SEC filing
Independent insiders buying near the same time
- 2024-03-22–2024-03-25: 4 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
- 2023-10-06–2023-10-13: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2023-09-06–2023-09-06: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2025-05-02 | Benesch Joseph · CFO | Common Stock, $0.0001 par value | S — Open market or private sale | −2,409 | 6.84 | SEC filing |
| 2025-05-02 | Maraoui Claude · President & CEO | Common Stock, $0.0001 par value | S — Open market or private sale | −4,834 | 6.84 | SEC filing |
| 2025-05-02 | Alloush Ramsey · COO | Common Stock, $0.0001 par value | S — Open market or private sale | −2,857 | 6.84 | SEC filing |
| 2025-03-11 | Maraoui Claude · President & CEO | Common Stock, $0.0001 par value | S — Open market or private sale | −49,271 | 5.01 | SEC filing |
| 2025-03-07 | Maraoui Claude · President & CEO | Common Stock, $0.0001 par value | S — Open market or private sale | −14,905 | 5.01 | SEC filing |
| 2025-03-06 | Maraoui Claude · President & CEO | Common Stock, $0.0001 par value | S — Open market or private sale | −25,551 | 5.04 | SEC filing |
| 2025-03-05 | Maraoui Claude · President & CEO | Common Stock, $0.0001 par value | S — Open market or private sale | −18,147 | 5.13 | SEC filing |
| 2025-03-04 | Maraoui Claude · President & CEO | Common Stock, $0.0001 par value | S — Open market or private sale | −28,901 | 5.04 | SEC filing |
Showing 8 of 19 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-25 | Herskowitz Neil · Director | Common Stock, $0.0001 par value | A — Grant, award, or other acquisition | +10,000 | SEC filing |
| 2026-06-25 | Smith Justin Adam · Director | Common Stock, $0.0001 par value | A — Grant, award, or other acquisition | +10,000 | SEC filing |
| 2026-06-25 | Toledano Miranda Jayne · Director | Common Stock, $0.0001 par value | A — Grant, award, or other acquisition | +10,000 | SEC filing |
| 2026-06-25 | Pearce Michael Cooper · Director | Common Stock, $0.0001 par value | A — Grant, award, or other acquisition | +10,000 | SEC filing |
| 2026-06-25 | ROSENWALD LINDSAY A MD · Director | Common Stock, $0.0001 par value | A — Grant, award, or other acquisition | +10,000 | SEC filing |
| 2026-04-22 | Benesch Joseph · CFO | Common Stock, $0.0001 par value | A — Grant, award, or other acquisition | +28,907 | SEC filing |
| 2026-04-22 | Alloush Ramsey · Chief Operating Officer | Common Stock, $0.0001 par value | A — Grant, award, or other acquisition | +46,863 | SEC filing |
| 2026-04-22 | Alloush Ramsey · Chief Operating Officer | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +62,795 | SEC filing |
Showing 8 of 13 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2023-05-12 | Fortress Biotech, Inc. · 10% owner | COMMON STOCK, PAR VALUE $0.0001 | J — Other acquisition or disposition | −50,000 | SEC filing |
| 2023-02-12 | Fortress Biotech, Inc. · 10% owner | COMMON STOCK, PAR VALUE $0.0001 | J — Other acquisition or disposition | −50,000 | SEC filing |
| 2022-11-12 | Fortress Biotech, Inc. · 10% owner | COMMON STOCK, PAR VALUE $0.0001 | J — Other acquisition or disposition | −50,000 | SEC filing |
| 2022-08-12 | Fortress Biotech, Inc. · 10% owner | COMMON STOCK, PAR VALUE $0.0001 | J — Other acquisition or disposition | −50,000 | SEC filing |
| 2022-05-12 | Fortress Biotech, Inc. · 10% owner | COMMON STOCK, PAR VALUE $0.0001 | J — Other acquisition or disposition | −50,000 | SEC filing |
Showing 5 of 5 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.